Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Sales

Burning Rock Biotech (BNR) FCF Margin: 2020-2025

Historic FCF Margin for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to 12.29%.

  • Burning Rock Biotech's FCF Margin rose 9319.00% to 12.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.66%, marking a year-over-year increase of 2885.00%. This contributed to the annual value of 18.94% for FY2024, which is 3016.00% up from last year.
  • According to the latest figures from Q3 2025, Burning Rock Biotech's FCF Margin is 12.29%, which was up 127.21% from 45.17% recorded in Q2 2025.
  • Over the past 5 years, Burning Rock Biotech's FCF Margin peaked at 17.27% during Q4 2024, and registered a low of 294.63% during Q4 2022.
  • Over the past 3 years, Burning Rock Biotech's median FCF Margin value was 32.01% (recorded in 2024), while the average stood at 33.00%.
  • Its FCF Margin has fluctuated over the past 5 years, first crashed by 22,039bps in 2022, then soared by 28,253bps in 2023.
  • MRQ analysis of 5 years shows Burning Rock Biotech's FCF Margin stood at 74.25% in 2021, then tumbled by 297bps to 294.63% in 2022, then soared by 96bps to 12.11% in 2023, then skyrocketed by 243bps to 17.27% in 2024, then decreased by 29bps to 12.29% in 2025.
  • Its FCF Margin was 12.29% in Q3 2025, compared to 45.17% in Q2 2025 and 17.68% in Q1 2025.